-
Recent Posts
- The EU says no to ACTA: to protect public health, other countries should also reject it
- Compulsory Licensing in India: A historic move to make drugs affordable
- Open letter to DG, WHO – Pentavalent vaccine related deaths in India
- Global Week of Action: India- EU Free Trade Agreement (FTA)
- A victory for Novartis could spell death for millions
Tags
ACTA AIDAN Annual Meet Book release Clinical Trials Conflict of Interest draft policy Drug Pricing Drug Promotion Essential Drugs essential medicines EU Generic drug Global Health Health India India-EU FTA IPR Letter Marketing Medical Council of India Medicine Medicine pricing Medicines National Pharmaceuticals Pricing Policy Patent Pharma Industry Pharma Policy Photo PIL Polio Price Control Rational Drugs Sec 3 (d) Supreme Court of India TRIPS Vaccine WHO WTOBlog Stats
- 42,100 hits
The homepage of All India Drug Action Network
I am a regular subscriber of MIMS and find its editorials very informative. You may like to consider the possibility of uploading if not all, at least some of them which are relaied to drug promotion, drug regulation, irrational drugs and clinical trials. MIMS can be contacted at indianmims@yahoo.co.in
Regards,